The following trials provide information to treat various types of gastrointestinal diseases, both for ongoing and completed clinical trials. For more information on this therapy area please click here.
- collapse An open-label, randomized, 4-treatment, 3-period, crossover interaction study, evaluating the effect of esomeprazole 40 mg, omeprazole 80 mg or lansoprazole 60 mg on the pharmacodynamics and the pharmacokinetics of clopidogrel in healthy volunteers
- collapse Comparative Efficacy & Safety Study of D961H Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With Low-dose Aspirin
- collapse A Randomised, Single Blind, Two-way Cross-over, Single-centre Study to Assess the Pharmacodynamics (Intragastric pH) and Pharmacokinetics After Repeated Oral Administration of D961H 10 mg and Omeprazole 10 mg in Japanese Healthy Male Subjects
- collapse A Phase I, Open-label, Randomized, Single-center, 2-way Crossover Food Interaction Study To Assess the Effect of Food on the Pharmacokinetics of the Fixed Dose Combination capsule of Esomeprazole 20 mg/Acetylsalicylic acid 81 mg
- collapse A double-blind, randomized, placebo-controlled, two-centre, phase IIa pharmacodynamic cross-over study to assess the effect of AZD2516 on the total number of reflux episodes in healthy male volunteers
- collapse Study of Incidence of Drug-induced Upper Gastrointestinal Bleeding
- collapse National Survey on GERD Patients (Adults and Children)
- collapse Diagnosis and Response to Treatment Using a Reliable Gerd Questionnaire-an In Clinical Practise Study.
- collapse Prevalence of GERD in Patients with upperGITsymptoms in Thailand
- collapse Partial Response to PPI treatment: The Cost to Society and the Burden to the Patient
